150 related articles for article (PubMed ID: 10526269)
1. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
3. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
5. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
[TBL] [Abstract][Full Text] [Related]
6. [Telomere length and DCC gene mRNA expression of human large intestine cancers].
Zhang F; Deng Z; Jia Z; Wei Y; Fan J; Wu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):187-90. PubMed ID: 11402446
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
Katayama S; Shiota G; Kawasaki H
Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
[TBL] [Abstract][Full Text] [Related]
9. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
11. The relationship between telomere length and telomerase activity in gynecologic cancers.
Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in ovarian tumors.
Murakami J; Nagai N; Ohama K; Tahara H; Ide T
Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
[TBL] [Abstract][Full Text] [Related]
13. Relationship between microsatellite instability and telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Nagashima F; Chida M; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S12-7. PubMed ID: 11052472
[TBL] [Abstract][Full Text] [Related]
14. Telomere length changes in colorectal cancers and polyps.
Kim HR; Kim YJ; Kim HJ; Kim SK; Lee JH
J Korean Med Sci; 2002 Jun; 17(3):360-5. PubMed ID: 12068140
[TBL] [Abstract][Full Text] [Related]
15. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in stage II colorectal carcinoma.
Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; Tubbs R; Elson P; Lavery I; Bukowski RM; Ganapathi R; Ganapathi MK
Cancer; 2002 Nov; 95(9):1834-9. PubMed ID: 12404275
[TBL] [Abstract][Full Text] [Related]
17. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
[TBL] [Abstract][Full Text] [Related]
19. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
20. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Hsu CP; Miaw J; Shai SE; Chen CY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
